In Vitro Diagnostics Market to 2018 - Consolidation, Decentralization and Demand for Genetic Testing to Shape the Competitive Landscape

In Vitro Diagnostics Market to 2018 - Consolidation, Decentralization and Demand for Genetic Testing to Shape the Competitive Landscape

Summary

GBI Research’s report, “In Vitro Diagnostics Market to 2018 - Consolidation, Decentralization and Demand for Genetic Testing to Shape the Competitive Landscape” provides key data, information and analysis on the global In Vitro Diagnostics (IVD) market. The report provides market landscape, competitive landscape and market trends information on seven IVD market categories: immunochemistry, clinical chemistry, infectious immunology, hematology, microbiology culture, histology and cytology and genetic testing. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, with analysis of the major Mergers and Acquisitions (M&A) in the last four years and a detailed analysis of the pipeline products in each category. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

- The key geographies include, the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia and Brazil.
- Market size data for seven In Vitro Diagnostics market categories – immunochemistry, clinical chemistry, infectious immunology, hematology, microbiology culture, histology and cytology and genetic testing.
- Annualized market revenue data, seven-year forecasts through to 2018, as well as company share data for 2010.
- Qualitative analysis of key market trends for the In Vitro Diagnostics market.
- Qualitative analysis of market drivers and restraints in each category within the In Vitro Diagnostics market.
- The report also covers information on the leading market players, the competitive landscape, and the leading technologies in the market

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the In Vitro Diagnostics market globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Identify the players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products most likely to ensure a robust return.
- What’s the next big thing in the the In Vitro Diagnostics market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global In Vitro Diagnostics market and the factors shaping it.

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 8
1.2 List of Figures 9
2 Introduction 11
2.1 GBI Research Guidance 11
3 Global In Vitro Diagnostics Market: Market Characterization 12
3.1 Global in Vitro Diagnostics Market, Revenue ($bn), 2004–2011 12
3.2 Global In Vitro Diagnostics Market, Revenue ($bn), 2011–2018 14
3.3 Global In Vitro Diagnostics Market, Key Company Shares (%), 2010 16
3.4 Global In Vitro Diagnostics Market: Key Market Trends 17
3.4.1 Growing Trend towards Preventive Healthcare is Driving the Growth of In Vitro Diagnostics 17
3.4.2 Increased Use of Information Technology in IVD for Effective Workflow Management 18
3.4.3 Laboratory Consolidation is a Major Trend in the IVD Industry 19
3.4.4 Demand for Decentralized Laboratory Testing is increasing Significantly Across the World 21
3.4.5 Consolidation Activity has Increased Significantly in the IVD Industry in Recent Years 21
3.4.6 Automation is the Key Technology Trend in IVD Market 22
3.5 Global In Vitro Diagnostics Market: Market Dynamics 24
3.5.1 Market Drivers 24
3.5.2 Market Restraints 25
4 Global In Vitro Diagnostics Market: Market Category Analysis and Forecasts 26
4.1 In Vitro Diagnostics Market: Cross-Category Analysis 26
4.2 Immunochemistry 28
4.2.1 Immunochemistry Market, Global, Revenue ($m), 2004–2011 28
4.2.2 Immunochemistry Market, Global, Revenue ($m), 2011–2018 29
4.2.3 Immunochemistry Market, Global, Company Share, (%), 2010 30
4.3 Immunochemistry Market: Market Dynamics 32
4.3.1 Market Drivers 32
4.3.2 Market Restraints 34
4.4 Clinical Chemistry 35
4.4.1 Clinical Chemistry Market, Global, Revenue ($m), 2004–2011 35
4.4.2 Clinical Chemistry Market, Global, Revenue ($m), 2011–2018 36
4.4.3 Clinical Chemistry Market, Global, Key Company Shares, (%), 2010 37
4.5 Clinical Chemistry Market: Market Dynamics 39
4.5.1 Market Drivers 39
4.5.2 Market Restraints 41
4.6 Infectious Immunology 42
4.6.1 Infectious Immunology Market, Global, Revenue ($m), 2004–2011 42
4.6.2 Infectious Immunology Market, Global, Revenue ($m), 2011–2018 43
4.6.3 Infectious Immunology Market, Global, Key Company Shares, (%), 2010 44
4.7 Infectious Immunology Market: Market Dynamics 45
4.7.1 Market Drivers 45
4.7.2 Market Restraints 46
4.8 Hematology 47
4.8.1 Hematology Market, Global, Revenue ($m), 2004–2011 47
4.8.2 Hematology Market, Global, Revenue ($m), 2011–2018 48
4.8.3 Hematology Market, Global, Key Company Shares, (%), 2010 49
4.9 Hematology Market: Market Dynamics 50
4.9.1 Market Drivers 50
4.9.2 Market Restraints 50
4.10 Microbiology Culture 51
4.10.1 Microbiology Culture Market, Global, Revenue ($m), 2004–2011 51
4.10.2 Microbiology Culture Market, Global, Revenue ($m), 2011–2018 52
4.10.3 Microbiology Culture Market, Global, Company Shares, (%), 2010 53
4.11 Microbiology Culture Market: Market Dynamics 54
4.11.1 Market Drivers 54
4.11.2 Market Restraints 54
4.12 Histology and Cytology 55
4.12.1 Histology and Cytology Market, Global, Revenue ($m), 2004–2011 55
4.12.2 Histology and Cytology Market, Global, Revenue ($m), 2011–2018 56
4.12.3 Histology and Cytology Market, Global, Company Share, (%), 2010 57
4.13 Histology and Cytology Market: Market Dynamics 58
4.13.1 Market Drivers 58
4.13.2 Market Restraints 58
4.14 Genetic Testing 59
4.14.1 Genetic Testing Market, Global, Revenue ($m), 2004–2011 59
4.14.2 Genetic Testing Market, Global, Revenue ($m), 2011–2018 60
4.14.3 Genetic Testing Market, Global, Company Share, (%), 2010 61
4.15 Genetic Testing Market: Market Dynamics 62
4.15.1 Market Drivers 62
4.15.2 Market Restraints 63
5 Global In Vitro Diagnostics Market: Country Analysis and Forecasts 64
5.1 In Vitro Diagnostics Market: Cross-Country Analysis 64
5.2 Historic and Forecast Revenue, By Country 66
5.2.1 In Vitro Diagnostics Market, The US, Revenue ($m), 2004–2011 66
5.2.2 In Vitro Diagnostics Market, the US, Revenue ($m), 2011–2018 67
5.2.3 In Vitro Diagnostics Market, Canada, Revenue ($m), 2004–2011. 68
5.2.4 In Vitro Diagnostics Market, Canada, Revenue ($m), 2011–2018 69
5.2.5 In Vitro Diagnostics Market, the UK, Revenue ($m), 2004–2011 70
5.2.6 In Vitro Diagnostics Market, the UK, Revenue ($m), 2011–2018 71
5.2.7 In Vitro Diagnostics Market, Germany, Revenue ($m), 2004–2011 72
5.2.8 In Vitro Diagnostics Market, Germany, Revenue ($m), 2011–2018 73
5.2.9 In Vitro Diagnostics Market, France, Revenue ($m), 2004–2011 74
5.2.10 In Vitro Diagnostics Market, France, Revenue ($m), 2011–2018 75
5.2.11 In Vitro Diagnostics Market, Italy, Revenue ($m), 2004–2011 76
5.2.12 In Vitro Diagnostics Market, Italy, Revenue ($m), 2011–2018 77
5.2.13 In Vitro Diagnostics Market, Spain, Revenue ($m), 2004–2011 78
5.2.14 In Vitro Diagnostics Market, Spain, Revenue ($m), 2011–2018 79
5.2.15 In Vitro Diagnostics Market, Japan, Revenue ($m), 2004–2011 80
5.2.16 In Vitro Diagnostics Market, Japan, Revenue ($m), 2011–2018 81
5.2.17 In Vitro Diagnostics Market, China, Revenue ($m), 2004–2011 82
5.2.18 In Vitro Diagnostics Market, China, Revenue ($m), 2011–2018 83
5.2.19 In Vitro Diagnostics Market, India, Revenue ($m), 2004–2011 84
5.2.20 In Vitro Diagnostics Market, India, Revenue ($m), 2011–2018 85
5.2.21 In Vitro Diagnostics Market, Australia, Revenue ($m), 2004–2011 86
5.2.22 In Vitro Diagnostics Market, Australia, Revenue ($m), 2011–2018 87
5.2.23 In Vitro Diagnostics Market, Brazil, Revenue ($m), 2004–2011 88
5.2.24 In Vitro Diagnostics Market, Brazil, Revenue ($m), 2011–2018 89
6 Global In Vitro Diagnostics Market: Competitive Assessment 90
6.1 Key Market Participants 91
6.1.1 F. Hoffmann–La Roche Ltd. 91
6.1.2 Siemens Healthcare (Subsidiary of Siemens AG) 92
6.1.3 Abbott Laboratories 93
6.1.4 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation) 94
6.1.5 Ortho–Clinical Diagnostics Inc. (Subsidiary of Johnson & Johnson) 95
6.1.6 bioMerieux S.A. (Subsidiary of Merieux Alliance group) 95
6.1.7 Sysmex Corporation (Sysmex) 96
6.1.8 Becton, Dickinson and Company 97
6.1.9 Bio–Rad Laboratories, Inc. (Bio–Rad) 98
6.1.10 Alere Inc. (formerly Inverness Medical Innovations, Inc.) 99
7 Global In Vitro Diagnostics Market: Product Pipeline Analysis 100
7.1 In Vitro Diagnostics Market: Pipeline Products Summary 100
7.1.1 Pipeline Products Analysis: Immunochemistry Market 102
7.1.2 Pipeline Products Analysis: Infectious Immunology 103
7.1.3 Pipeline Products Analysis: Genetic Testing 104
7.1.4 Pipeline Products Analysis: Clinical Chemistry 105
7.1.5 Pipeline Products Analysis: Hematology 106
7.1.6 Pipeline Products Analysis: Microbiology Culture 107
7.1.7 Pipeline Products Analysis: Histology and Cytology 108
7.2 In Vitro Diagnostics Market: Profiles of Key Pipeline Products 109
7.2.1 ImmProCon Technology 109
7.2.2 RAPIDPoint 500 System – Lactate Assay 109
7.2.3 Sali – Chek Reader 109
7.2.4 Point-of-Care Diagnostic Device 110
7.2.5 ACE Alera Clinical Chemistry System – Direct A1c Assay 110
7.2.6 Advia 120 Hematology System – IRF Test 110
7.2.7 Advia 2120 Hematology System – MPC Test 111
7.2.8 AIA–600 II – D–dimer Test 111
8 Global In Vitro Diagnostics Market: Consolidation Landscape 112
8.1 Deals by Number, 2008–2011 112
8.2 In Vitro Diagnostics Market: Key Deals, 2008–2011 120
8.2.1 Roche Completes Acquisition of mtm laboratories 120
8.2.2 bioMerieux Acquires Argene 120
8.2.3 Thermo Fisher Completes Acquisition of Phadia 120
8.2.4 Quest Diagnostics Completes Acquisition of Athena Diagnostics 121
8.2.5 Danaher Completes Acquisition of Beckman Coulter 121
8.2.6 Laboratory Corporation of America Completes Acquisition of Genzyme Genetics From Genzyme 122
8.2.7 Merck Completes Acquisition of Millipore 122
8.2.8 Thermo Fisher Scientific Completes Acquisition of Ahura Scientific 122
8.2.9 Inverness Medical Innovations Acquires 78.13% Stake in Standard Diagnostics 123
8.2.10 Quidel Completes Acquisition of Diagnostic HYBRIDS 123
8.2.11 Danaher Completes Acquisition of Genetix Group 123
8.2.12 QIAGEN Completes Acquisition of DxS 123
8.2.13 Thermo Fisher Scientific Completes Acquisition of B.R.A.H.M.S. 124
8.2.14 Laboratory Corporation of America Holdings Completes Acquisition of Monogram Biosciences 124
8.2.15 Inverness Medical Innovations Completes Acquisition of Concateno From Marwyn 125
8.2.16 Gen–Probe Acquires Tepnel Life Sciences 125
8.2.17 Hologic Acquires Third Wave Technologies 125
8.2.18 Immucor Acquires BioArray Solutions 125
8.2.19 Werfen Life Acquires INOVA Diagnostics 126
8.2.20 Abbott Laboratories Acquires Ibis Biosciences from Isis Pharmaceuticals 126
8.2.21 bioMerieux Acquires AviaraDx 126
8.2.22 Bio–Rad Laboratories Acquires Diamed 127
9 Appendix 128
9.1 Definitions 128
9.1.1 Clinical Chemistry 128
9.1.2 Immunochemistry Test Reagents 129
9.1.3 Hematology 130
9.1.4 Histology And Cytology 131
9.1.5 Microbiology Culture 132
9.1.6 Infectious Immunology 132
9.1.7 Genetic Testing 133
9.2 Sources 133
9.3 Acronyms 133
9.4 Research Methodology 134
9.4.1 Secondary Research 134
9.4.2 Primary Research 135
9.4.3 Models 135
9.4.4 Forecasts 135
9.4.5 Expert Panels 135
9.5 Contact Us 136
9.6 Disclaimer 136

1.1 List of Tables
Table 1: In Vitro Diagnostics Market, Global, Revenue ($bn), 2004–2011 12
Table 2: In Vitro Diagnostics Market, Global, Revenue ($bn), 2011–2018 14
Table 3: Global In Vitro Diagnostics Market, Key Company, Revenue ($m) 2010 16
Table 4: In Vitro Diagnostics Market, Global, Diagnostics Laboratories, Key M&A Deals, 2007 19
Table 5: In Vitro Diagnostics Market, Global, Diagnostics Laboratories, Key M&A Deals, 2008–2009 20
Table 6: Key M&A, IVD Market, Global, 2010–2011 22
Table 7: In Vitro Diagnostics Market, Global, Cross Category Analysis ,CAGR (%), 2004–2018 26
Table 8: Immunochemistry Market, Global, Revenue ($m), 2004–2011 28
Table 9: Immunochemistry Market, Global, Revenue ($m), 2011–2018 29
Table 10: Global Immunochemistry Market, Key Company, Revenue ($m) 2010 31
Table 11: Global Immunochemistry Market, Tumor Markers 33
Table 12: Clinical Chemistry Market, Global, Revenue ($m), 2004–2011 35
Table 13: Clinical Chemistry Market, Global, Revenue ($m), 2011–2018 36
Table 14: Clinical Chemistry Market, Global, Key Company Revenue ($m), 2010 38
Table 15: Infectious Immunology Market, Global, Revenue ($m), 2004–2011 42
Table 16: Infectious Immunology Market, Global, Revenue ($m), 2011–2018 43
Table 17: Infectious Immunology Market, Global, Key Company, Revenue ($m) 2010 44
Table 18: Hematology Market, Global, Revenue ($m), 2004–2011 47
Table 19: Hematology Market, Global, Revenue ($m), 2011–2018 48
Table 20: Hematology Market, Global, Key Company Revenue ($m), 2010 49
Table 21: Microbiology Culture Market, Global, Revenue ($m), 2004–2011 51
Table 22: Microbiology Culture Market, Global, Revenue ($m), 2011–2018 53
Table 23: Microbiology Culture Market, Global, Key Company Revenue ($m), 2010 54
Table 24: Histology and Cytology Market, Global, Revenue ($m), 2004–2011 55
Table 25: Histology and Cytology Market, Global, Revenue ($m), 2011–2018 56
Table 26: Histology and Cytology Market, Global, Key Company, Revenue ($m) 2010 57
Table 27: Genetic Testing Market, Global, Revenue ($m), 2004–2011 59
Table 28: Genetic Testing Market, Global, Revenue ($m), 2011–2018 60
Table 29: Genetic Testing Market, Global, Key Company Revenue ($m), 2010 61
Table 30: In Vitro Diagnostics Market, Global, Genetic Testing, Home Genetic Test Kits, Examples 62
Table 31: IVD Market, Global, Cross-Country Analysis, CAGR (%), 2004–2018 64
Table 32: In Vitro Diagnostics Market, The US, Revenue ($m), 2004–2011 66
Table 33: In Vitro Diagnostics Market, The US, Revenue ($m), 2011–2018 67
Table 34: In Vitro Diagnostics Market, Canada, Revenue ($m), 2004–2011 68
Table 35: In Vitro Diagnostics Market, Canada, Revenue ($m), 2011–2018 69
Table 36: In Vitro Diagnostics Market, The UK, Revenue ($m), 2004–2011 70
Table 37: In Vitro Diagnostics Market, The UK, Revenue ($m), 2011–2018 71
Table 38: In Vitro Diagnostics Market, Germany, Revenue ($m), 2004–2011 72
Table 39: In Vitro Diagnostics Market, the Germany, Revenue ($m), 2011–2018 73
Table 40: In Vitro Diagnostics Market, France, Revenue ($m), 2004–2011 74
Table 41: In Vitro Diagnostics Market, France, Revenue ($m), 2011–2018 75
Table 42: In Vitro Diagnostics Market, Italy, Revenue ($m), 2004–2011 76
Table 43: In Vitro Diagnostics Market, Italy, Revenue ($m), 2011–2018 77
Table 44: In Vitro Diagnostics Market, Spain, Revenue ($m), 2004–2011 78
Table 45: In Vitro Diagnostics Market, Spain, Revenue ($m), 2011–2018 79
Table 46: In Vitro Diagnostics Market, Japan, Revenue ($m), 2004–2011 80
Table 47: In Vitro Diagnostics Market, Japan, Revenue ($m), 2011–2018 81
Table 48: In Vitro Diagnostics Market, China, Revenue ($m), 2004–2011 82
Table 49: In Vitro Diagnostics Market, China, Revenue ($m), 2011–2018 83
Table 50: In Vitro Diagnostics Market, India, Revenue ($m), 2004–2011 84
Table 51: In Vitro Diagnostics Market, India, Revenue ($m), 2011–2018 85
Table 52: In Vitro Diagnostics Market, Australia, Revenue ($m), 2004–2011 86
Table 53: In Vitro Diagnostics Market, Australia, Revenue ($m), 2011–2018 87
Table 54: In Vitro Diagnostics Market, Brazil, Revenue ($m), 2004–2011 88
Table 55: In Vitro Diagnostics Market, Brazil, Revenue ($m), 2011–2018 89
Table 56: In Vitro Diagnostics (IVD) Market, Global, Pipeline Products by Category, 2011 100
Table 57: In Vitro Diagnostics Market, Pipeline Assessment, by Development Stage 101
Table 58: Immunochemistry Market, Global, Pipeline Products Analysis, 2011 102
Table 59: Infectious Immunology Market, Global, Pipeline Products Analysis, 2011 103
Table 60: Genetic Testing Market, Global, Pipeline Products Analysis, 2011 104
Table 61: Clinical Chemistry Market, Global, Pipeline Products Analysis, 2011 105
Table 62: Hematology Market, Global, Pipeline Products Analysis, 2011 106
Table 63: Microbiology Culture Market, Global, Pipeline Products Analysis, 2011 107
Table 64: Histology and Cytology Market, Global, Pipeline Products Analysis, 2011 108
Table 65: ImmProCon Technology, Product Status, 2011 109
Table 66: RAPIDPoint 500 System, Product Status, 2011 109
Table 67: Sali – Chek Reader, Product Status, 2011 109
Table 68: Point-of-Care Diagnostic Device, Product Status, 2011 110
Table 69: ACE Alera Clinical Chemistry System – Direct A1c Assay, Product Status, 2011 110
Table 70: Advia 120 Hematology System – IRF (Immature Reticulocyte Fraction) Test, Product Status, 2011 110
Table 71: Advia 2120 Hematology System – MPC (Mean Platelet Component) Test, Product Status, 2011 111
Table 72: AIA (Automated Immunoassay Analyzer)–600 II – D–dimer Test, Product Status, 2011 111
Table 73: IVD Market, Mergers and Acquisitions, Number of Deals, Global, 2008–2011 112
Table 74: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2008 113
Table 75: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2009 – Table 1 114
Table 76: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2009 – Table 2 115
Table 77: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2010 – Table 1 116
Table 78: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2010 – Table 2 117
Table 79: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2011 – Table 1 118
Table 80: In Vitro Diagnostics Market, Global, Mergers and Acquisitions, 2011 – Table 2 119

1.2 List of Figures
Figure 1: In Vitro Diagnostics Market, Global, Revenue ($bn), 2004–2011 12
Figure 2: In Vitro Diagnostics Market, Global, Revenue ($bn), 2011–2018 14
Figure 3: Global In Vitro Diagnostics Market, Key Company Shares (%), 2010 16
Figure 4: In Vitro Diagnostics Market, Global, Cross-Category Analysis , CAGR (%), 2004–2018 26
Figure 5: Immunochemistry Market, Global, Revenue ($m), 2004–2011 28
Figure 6: Immunochemistry Market, Global, Revenue ($m), 2011–2018 29
Figure 7: Immunochemistry Market, Global, Company Share, (%), 2010 30
Figure 8: Clinical Chemistry Rapid Tests & POC Market, Global, Revenue ($m), 2004–2011 35
Figure 9: Clinical Chemistry Market, Global, Revenue ($m), 2011–2018 36
Figure 10: Clinical Chemistry Market, Global, Key Company, Revenues ($m) 2010 37
Figure 11: Infectious Immunology Market, Global, Revenue ($m), 2004–2011 42
Figure 12: Infectious Immunology Market, Global, Revenue ($m), 2011–2018 43
Figure 13: Infectious Immunology Market, Global, Key Company Shares, (%), 2010 44
Figure 14: Hematology Market, Global, Revenue ($m), 2004–2011 47
Figure 15: Hematology Market, Global, Revenue ($m), 2011–2018 48
Figure 16: Hematology Market, Global, Key Company Shares, (%), 2010 49
Figure 17: Microbiology Culture Market, Global, Revenue ($m), 2004–2011 51
Figure 18: Microbiology Culture Market, Global, Revenue ($m), 2011–2018 52
Figure 19: Microbiology Culture Market, Global, Company Shares, (%), 2010 53
Figure 20: Histology and Cytology Market, Global, Revenue ($m), 2004–2011 55
Figure 21: Histology and Cytology Market, Global, Revenue ($m), 2011–2018 56
Figure 22: Histology and Cytology Market, Global, Company Share, (%), 2010 57
Figure 23: Genetic Testing Market, Global, Revenue ($m), 2004–2011 59
Figure 24: Genetic Testing Market, Global, Revenue ($m), 2011–2018 60
Figure 25: Genetic Testing Market, Global, Company Share, (%), 2010 61
Figure 26: In Vitro Diagnostics Market, Global, Cross-Country Analysis, CAGR (%), 2004–2018 64
Figure 27: In Vitro Diagnostics Market, The US, Revenue ($m), 2004–2011 66
Figure 28: In Vitro Diagnostics Market, the US, Revenue ($m), 2011–2018 67
Figure 29: In Vitro Diagnostics Market, Canada, Revenue ($m), 2004–2011 68
Figure 30: In Vitro Diagnostics Market, Canada, Revenue ($m), 2011–2018 69
Figure 31: In Vitro Diagnostics Market, The UK, Revenue ($m), 2004–2011 70
Figure 32: In Vitro Diagnostics Market, The UK, Revenue ($m), 2011–2018 71
Figure 33: In Vitro Diagnostics Market, Germany, Revenue ($m), 2004–2011 72
Figure 34: In Vitro Diagnostics Market, the Germany, Revenue ($m), 2011–2018 73
Figure 35: In Vitro Diagnostics Market, France, Revenue ($m), 2004–2011 74
Figure 36: In Vitro Diagnostics Market, France, Revenue ($m), 2011–2018 75
Figure 37: In Vitro Diagnostics Market, Italy, Revenue ($m), 2004–2011 76
Figure 38: In Vitro Diagnostics Market, Italy, Revenue ($m), 2011–2018 77
Figure 39: In Vitro Diagnostics Market, Spain, Revenue ($m), 2004–2011 78
Figure 40: In Vitro Diagnostics Market, Spain, Revenue ($m), 2011–2018 79
Figure 41: In Vitro Diagnostics Market, Japan, Revenue ($m), 2004–2011 80
Figure 42: In Vitro Diagnostics Market, Japan, Revenue ($m), 2011–2018 81
Figure 43: In Vitro Diagnostics Market, China, Revenue ($m), 2004–2011 82
Figure 44: In Vitro Diagnostics Market, China, Revenue ($m), 2011–2018 83
Figure 45: In Vitro Diagnostics Market, India, Revenue ($m), 2004–2011 84
Figure 46: In Vitro Diagnostics Market, India, Revenue ($m), 2011–2018 85
Figure 47: In Vitro Diagnostics Market, Australia, Revenue ($m), 2004–2011 86
Figure 48: In Vitro Diagnostics Market, Australia, Revenue ($m), 2011–2018 87
Figure 49: In Vitro Diagnostics Market, Brazil, Revenue ($m), 2004–2011 88
Figure 50: In Vitro Diagnostics Market, Brazil, Revenue ($m), 2011–2018 89
Figure 51: In Vitro Diagnostics Market, Global, Competitive Assessment 90
Figure 52: In Vitro Diagnostics Market, Global, Pipeline Product Summary (%), 2010 100
Figure 53: In Vitro Diagnostics Market, Pipeline Assessment, by Development Stage 101
Figure 54: Immunochemistry Market, Global, Pipeline Products Analysis, 2011 102
Figure 55: Infectious Immunology Market, Global, Pipeline Products Analysis, 2011 103
Figure 56: Genetic Testing Market, Global, Pipeline Products Analysis, 2011 104
Figure 57: Clinical Chemistry Market, Global, Pipeline Products Analysis, 2011 105
Figure 58: Hematology Market, Global, Pipeline Products Analysis, 2011 106
Figure 59: Microbiology Culture Market, Global, Pipeline Products Analysis, 2011 107
Figure 60: Histology and Cytology Market, Global, Pipeline Products Analysis, 2011 108
Figure 61: Cardiovascular Devices Market, Mergers and Acquisitions, Number of Deals, Global, 2008–2011 112